Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate. (Q42832493)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

title

Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Nicholas L Calistri

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Selim Olcum

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Ahmed Idbaih

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

15

Patrick Y Wen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

18

Scott R Manalis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

author name string

Mark M Stevens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Cecile L Maire

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Nigel Chou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Mark A Murakami

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Yuki Kikuchi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Robert J Kimmerling

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Huiyun Liu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Samer Haidar

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Nathan Cermak

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Nicolas A Cordero

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

David M Weinstock

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Keith L Ligon

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

publication date

10 October 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

page(s)

1161-1167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nbt.3697

25 March 2020

exact match

0 references

cites work

High-throughput measurement of single-cell growth rates using serial microfluidic mass sensor arrays.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Precision medicine for cancer with next-generation functional diagnostics

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Characterizing Cellular Biophysical Responses to Stress by Relating Density, Deformability, and Size

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Quantification of cell viability and rapid screening anti-cancer drug utilizing nanomechanical fluctuation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

A distinct p53 target gene set predicts for response to the selective p53-HDM2 inhibitor NVP-CGM097.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Patient-derived models of acquired resistance can identify effective drug combinations for cancer.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Single-cell RNA-seq reveals dynamic paracrine control of cellular variation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Inconsistency in large pharmacogenomic studies

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

What a tangled web we weave: emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathway

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Genomic impact of transient low-dose decitabine treatment on primary AML cells

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Ponatinib in refractory Philadelphia chromosome-positive leukemias

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Direct observation of mammalian cell growth and size regulation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Circumventing cancer drug resistance in the era of personalized medicine

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Evidence for label-retaining tumour-initiating cells in human glioblastoma

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Tumour evolution inferred by single-cell sequencing

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Using buoyant mass to measure the growth of single cells

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Weighing of biomolecules, single cells and single nanoparticles in fluid.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142231

Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas

16 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNBT.3697

Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNBT.3697

Acute lymphoblastic leukemia

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27723727

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NBT.3697

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27723727%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference